Skip to main content
. 2018 Sep 14;18(Suppl 3):74. doi: 10.1186/s12911-018-0654-2

Table 2.

Summary of first experiment

Diseases Number of patients Evaluation
Annotations MetaMap cTAKES MetaMap cTAKES
Recall Precision F-score Recall Precision F-score
Hypertension 325 336 340 0.99 0.96 0.98 0.99 0.95 0.97
Diabetesa 259 186 235 0.65 0.91 0.76 0.83 0.91 0.87
Atherosclerotic Cardiovascular Disease (CAD)a 181 95 199 0.45 0.86 0.59 0.92 0.84 0.88
Congestive Heart Failure (CHF) 172 175 183 0.89 0.87 0.88 0.92 0.86 0.89
Hypercholesterolemiaa 172 108 92 0.59 0.94 0.73 0.51 0.95 0.66
Obstructive Sleep Apnea (OSA) 127 105 102 0.78 0.94 0.85 0.76 0.94 0.84
Osteoarthritis (OA)a 87 76 61 0.76 0.87 0.81 0.67 0.95 0.78
Depressiona 83 105 116 0.89 0.70 0.79 0.99 0.71 0.82
Asthma 81 83 92 0.93 0.90 0.91 1.00 0.88 0.94
Gastroesophageal Reflux Disease (GERD) 76 83 85 0.97 0.89 0.93 0.99 0.88 0.93
Gallstones/Cholecystectomya 74 54 58 0.73 1.00 0.84 0.78 1.00 0.88
Gout 56 58 58 0.98 0.95 0.96 0.98 0.95 0.96
Peripheral Vascular Disease (PVD) 37 37 32 0.97 0.97 0.97 0.84 0.97 0.90
Venous Insufficiencya 21 6 6 0.29 1.00 0.44 0.29 1.00 0.44
AVERAGE 0.78 0.91 0.82 0.82 0.91 0.84

The lowest values for recall and precision are in bold

aDisease with low evaluation